Načítá se...
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
PURPOSE: The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. PATIENTS AND METHODS: This is a retrospective study tha...
Uloženo v:
| Vydáno v: | Clin Ophthalmol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7306461/ https://ncbi.nlm.nih.gov/pubmed/32606577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S252253 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|